PCSA Financials

Processa Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$2.98

Market Cap

$7.95M

EPS

$-10.36

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-11.85M

EPS (Diluted)

$-3.87

Balance Sheet Highlights

Total Assets

$3.23M

Total Liabilities

$1.53M

Shareholders Equity

Cash & Equivalents

$1.19M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-11.25M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-3.7%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is PCSA revenue?

View PCSA's income statement for detailed revenue data.

Is PCSA profitable?

PCSA reported a loss of $11.85M in the most recent quarter.

What is PCSA market cap?

PCSA has a market capitalization of $7.95M, making it a small-cap stock.

Does PCSA have debt?

View PCSA's balance sheet for debt information.

What is PCSA cash flow?

Cash flow data is available in the full financial statements.